Source: Medicines & Healthcare Products Regulatory Agency (GB) Revision Year: 2018 Publisher: Colonis Pharma Limited, Quantum House, Hobson Industrial Estate, Burnopfield County Durham, NE16 6EA, United Kingdom
Mucolytic adjuvant in the therapy of respiratory disorders associated with thick, viscous, mucus hypersecretion.
200 mg (1 sachet) 3 times a day. Maximum recommended daily dose 600 mg/day.
The duration of therapy is dependent on the nature and severity of the illness, and should be decided by the doctor treating the patient for adults and adolescents.
Abundant fluid intake supports the mucolytic effect of acetylcysteine.
Dissolve the contents of one sachet completely in a glass containing a little water just before use, stirring as needed with a teaspoon.
An acute overdose of acetylcysteine can cause gastrointestinal symptoms such as nausea, vomiting and diarrhoea.
Treatment of overdose is to be symptomatic and supportive treatment as indicated by the patient’s clinical condition.
3 years.
After reconstitution, the product must be administered immediately.
Store in the original package to protect from moisture.
Paper/aluminium/polyethylene sachet containing l g powder for oral solution, packaged in a cardboard box, in the following pack sizes: 10, 18, 20, 30 sachets.
Not all pack sizes may be marketed.
No special requirements for disposal. Any unused product should be disposed of in accordance with local requirements.
© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.
